Novartis - rapidly running out of friends in India

Indian treatment access activists demonstrating against Novartis' legal challenge against the Indian patent regime. Novartis' success, as I reported earlier, would put at risk the Indian production of cheap generics (eg for the treatment of HIV/AIDS in many developing countries).

Novartis vs the developing world's poor

The Swiss company Novartis is taking the Indian government to court
over its legislation pertaining to generic drugs. Novartis wants to
make it more difficult for Indian companies to produce generic drugs.
According to a report at nature.com MSF is collecting signature under
a petition calling on Novartis to drop the case. The medical charity
points out that 'India is the pharmacy for the developing world'.

Further information about the background to the MSF campaign can be found here.


The petition is available here